Recently, China’s National Healthcare Security Administration announced the nationwide launch of the ‘Medical Insurance Drug Price Comparison Mini Program.’ This tool aims to enhance price transparency for prescription drugs and help insured individuals quickly compare prices and reimbursement details across pharmacies and hospitals, enabling more cost-effective and informed medication choices. Users can simply search for ‘Medical Insurance Drug Price Comparison’ in WeChat or Alipay to access the mini program. By entering a drug name or scanning a barcode, they instantly receive real-time information on the drug’s price at nearby designated medical institutions, whether it is covered by insurance, and the patient’s out-of-pocket percentage. The platform also allows filtering by therapeutic effect, dosage form, brand, and other criteria to help users find the most suitable options. This initiative represents a significant step in the government’s ‘Internet + Medical Insurance’ strategy, helping curb inflated drug prices, reduce duplicate purchases, minimize waste, and improve the efficiency of medical insurance fund utilization. Going forward, authorities plan to further refine features and expand coverage to deliver a smarter, more convenient healthcare experience for the public.
近日，国家医保局宣布‘医保药品比价小程序’已在全国范围内全面上线。该小程序旨在提升药品价格透明度，方便参保群众在购药时快速比较不同药店、医院的药品价格及医保报销情况，从而做出更经济、合理的用药选择。用户只需通过微信或支付宝搜索‘医保药品比价’，即可进入小程序，输入药品名称或扫描条形码，系统将实时显示该药品在附近定点医药机构的价格、是否纳入医保目录、个人自付比例等关键信息。此外，小程序还支持按疗效、剂型、品牌等维度筛选，帮助用户精准匹配所需药品。这一举措是国家推动‘互联网+医保’服务的重要成果，有助于遏制药价虚高、减少重复购药和资源浪费，同时提升医保基金使用效率。未来，医保部门还将持续优化功能，拓展覆盖范围，为公众提供更加便捷、智能的医保服务体验。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/15618.html